Obstetric and Gynecologic Imaging

What Follow-Up Imaging Is Best for Monochorionic Twins After the Second Trimester Anatomy Scan?

·
What Follow-Up Imaging Is Best for Monochorionic Twins After the Second Trimester Anatomy Scan?

A 28-year-old G1P0 patient presents for her routine 20-week anatomy ultrasound. The scan confirms a monochorionic, diamniotic twin gestation. While no gross structural anomalies are seen, there appears to be a mild discrepancy in amniotic fluid volume between the two sacs, and one fetus appears subjectively smaller than the other. The ordering physician now faces a critical decision: what is the appropriate next imaging step to assess for the unique complications of a shared placenta? This isn’t just a routine growth scan; it requires a specific protocol to evaluate for life-threatening conditions.

This article provides a clinical workflow for follow-up imaging in second-trimester monochorionic twin gestations, guided by the American College of Radiology (ACR) Appropriateness Criteria. For this specific scenario, a dedicated US assessment for TTTS is rated Usually Appropriate as the primary recommended study.

Who Fits This Clinical Scenario?

This guidance is specifically for clinicians managing a patient with a confirmed monochorionic twin pregnancy who has completed their standard second-trimester anatomic survey (typically between 18 and 22 weeks) and now requires follow-up surveillance imaging. The core indication is the inherent high-risk nature of monochorionicity, which necessitates serial evaluation for specific complications.

Inclusion Criteria:

  • Confirmed monochorionic twin gestation (one placenta). This can be monochorionic-diamniotic or monochorionic-monoamniotic.
  • Patient is in the second trimester, post-anatomy scan.
  • The purpose of the imaging is surveillance and screening for complications unique to monochorionicity.

Exclusion Criteria (These route to different ACR guidelines):

  • First-trimester evaluation: Initial dating, viability, and chorionicity determination are covered under a different ACR variant. This workflow assumes chorionicity is already established.
  • Dichorionic twins: Patients with two separate placentas have a different risk profile and surveillance protocol, primarily focused on monitoring individual fetal growth and well-being.
  • Known major fetal anomaly: If a significant structural or genetic abnormality has already been diagnosed in one or both twins, the imaging workup is guided by that specific finding, which represents a separate clinical scenario.

What Diagnoses Are You Working Up in This Scenario?

Follow-up imaging in monochorionic twins is not simply about growth. It is an active search for a specific spectrum of diseases arising from the shared placental circulation. The differential diagnosis is narrow but critical, as these conditions can progress rapidly.

Twin-Twin Transfusion Syndrome (TTTS): This is the most feared complication and the primary target of surveillance. It occurs when unbalanced blood flow develops between the twins through shared placental vascular connections (anastomoses). One twin (the “donor”) effectively pumps blood to the other (the “recipient”), leading to a cascade of problems. The donor becomes anemic and dehydrated with low urine output (oligohydramnios), while the recipient becomes overloaded with blood (polycythemic) and fluid, leading to high urine output (polyhydramnios) and potential heart failure.

Selective Fetal Growth Restriction (sFGR): This condition results from unequal sharing of the placenta, where one twin receives a disproportionately small portion of the placental territory. This leads to poor growth in one fetus while the co-twin grows normally. While it can overlap with TTTS, sFGR is a distinct entity related to placental “real estate” rather than dynamic blood shunting.

Twin Anemia Polycythemia Sequence (TAPS): TAPS is a more subtle form of chronic, slow blood transfusion through very small placental anastomoses. Unlike TTTS, it is not characterized by amniotic fluid discrepancies. Instead, one twin becomes chronically anemic (pale) and the other polycythemic (ruddy). It is diagnosed primarily with Doppler ultrasound of the middle cerebral artery (MCA).

Normal Discordant Growth: It is also possible for monochorionic twins to have a size difference that does not meet the criteria for sFGR and is not associated with TTTS or TAPS. Differentiating this from early pathology is a key goal of serial imaging.

Why Is a Dedicated Ultrasound Assessment for TTTS the Recommended Study?

The ACR designates a specialized US assessment for TTTS as Usually Appropriate because a standard fetal growth scan is insufficient to screen for the complex vascular complications of monochorionicity. This dedicated examination is a multi-part assessment designed to detect the earliest signs of TTTS, sFGR, and TAPS.

This comprehensive ultrasound includes several key components:

  • Biometry and Estimated Fetal Weight (EFW): To assess for growth discordance and diagnose sFGR.
  • Amniotic Fluid Assessment: Measurement of the maximal vertical pocket (MVP) in each sac is crucial. The hallmark of TTTS is polyhydramnios (MVP >8 cm) in the recipient’s sac and oligohydramnios (MVP <2 cm) in the donor's sac.
  • Fetal Bladder Visualization: The donor twin’s bladder is often small or non-visible due to low urine output, while the recipient’s is typically enlarged and cycling quickly.
  • Doppler Studies: These are essential for diagnosis and staging. A US duplex Doppler fetal umbilical artery is Usually Appropriate to assess placental function and risk of adverse outcomes. A US duplex Doppler fetal middle cerebral artery is rated May be appropriate and is specifically added to the protocol to screen for TAPS by measuring peak systolic velocity (PSV), which is elevated in anemia and decreased in polycythemia.

Other studies like a US pregnant uterus transabdominal and US echocardiography fetal are also rated Usually Appropriate as they form part of the comprehensive evaluation. Fetal echocardiography is particularly important for the recipient twin in TTTS, who is at high risk for cardiac dysfunction.

Why are alternatives rated lower?

A US pregnant uterus biophysical profile (BPP) is rated Usually not appropriate for this specific screening scenario. The BPP is a test of acute fetal well-being (evaluating tone, breathing, movement, and fluid). While useful later in gestation for antepartum surveillance, it is not a primary diagnostic tool for the underlying pathophysiology of TTTS or sFGR in the second trimester. The diagnosis relies on the specific criteria of fluid discordance and Doppler findings, not the BPP score.

Similarly, MRI fetal without and with IV contrast is rated Usually not appropriate. Gadolinium-based contrast agents are generally avoided in pregnancy. While a non-contrast fetal MRI (May be appropriate) can be a problem-solving tool for complex anomalies, it offers no advantage over ultrasound for the routine surveillance and diagnosis of TTTS, sFGR, or TAPS and is not the standard of care.

All recommended ultrasound and MRI procedures for this scenario are non-ionizing and carry a radiation level of 0 mSv.

What’s Next After the Ultrasound? Downstream Workflow

The results of the comprehensive ultrasound dictate the subsequent management, which often requires a rapid and coordinated response.

  • If the study is positive for TTTS: This is a time-sensitive emergency. The patient requires immediate referral to a high-risk perinatal center with expertise in fetal therapy. The diagnosis is staged using the Quintero classification system (Stage I-V) based on the ultrasound findings. The primary treatment for severe, early-onset TTTS is fetoscopic laser ablation of the communicating placental vessels.
  • If the study is positive for sFGR or TAPS: Management depends on the severity and gestational age. This also warrants immediate consultation with a Maternal-Fetal Medicine (MFM) specialist. The workflow involves intensified surveillance, often weekly or bi-weekly, with Doppler studies to monitor for deterioration. Decisions regarding delivery timing are complex and individualized.
  • If the study is negative: A normal result is reassuring but does not eliminate future risk. The standard of care is to continue serial surveillance with this same comprehensive ultrasound every two weeks from 16 weeks until delivery to ensure early detection of any developing complications.
  • If the study is indeterminate: In cases with borderline findings (e.g., mild fluid discordance without meeting full TTTS criteria), the frequency of surveillance is typically increased to weekly. This “pre-TTTS” stage requires close observation as it can progress to overt TTTS quickly.

Pitfalls to Avoid (and When to Get Help)

Navigating the surveillance of monochorionic twins requires meticulous attention to detail. Common pitfalls include:

  • Infrequent Surveillance: Performing scans less frequently than every two weeks can miss the rapid onset of TTTS. The standard is every two weeks starting at 16 weeks.
  • Incomplete Assessment: Failing to measure all required components, especially MCA Dopplers for TAPS screening or umbilical artery Dopplers, can lead to a missed or delayed diagnosis.
  • Misattributing Findings: Confusing sFGR with TTTS can lead to inappropriate counseling, as the underlying pathophysiology and management strategies differ.
  • Delaying Referral: Any findings suggestive of TTTS (Quintero Stage I or higher) warrant immediate consultation with an MFM specialist at a fetal therapy center. Delaying this referral can compromise the window for effective intervention.

If there is any uncertainty in the diagnosis or if signs of TTTS, sFGR, or TAPS are present, the situation must be escalated immediately to a Maternal-Fetal Medicine specialist.

Related ACR Topics and Tools

For a comprehensive overview of imaging across all scenarios in this complex clinical area, please refer to our parent topic hub article. For additional tools to assist in clinical decision-making, see the resources below.

Frequently Asked Questions

How often should surveillance ultrasound be performed for uncomplicated monochorionic twins?

The generally accepted standard of care, supported by societies like the Society for Maternal-Fetal Medicine (SMFM), is to perform serial comprehensive ultrasounds every two weeks, starting from 16 weeks of gestation and continuing until delivery.

What is the difference between TTTS and sFGR on ultrasound?

The key differentiator is amniotic fluid. TTTS is defined by the combination of oligohydramnios (low fluid) in the donor’s sac and polyhydramnios (high fluid) in the recipient’s sac. In sFGR, the growth-restricted twin may have low fluid, but the larger co-twin typically has normal amniotic fluid volume, not polyhydramnios.

When should I specifically order Middle Cerebral Artery (MCA) Dopplers?

MCA Dopplers should be a routine part of every surveillance scan for monochorionic twins from 16-18 weeks onward. They are essential for screening for Twin Anemia Polycythemia Sequence (TAPS), a condition that may not have the obvious fluid discrepancies seen in TTTS. The ACR rates US duplex Doppler fetal middle cerebral artery as ‘May be appropriate’ as a standalone order but it is considered integral to a complete TTTS assessment.

Is a transvaginal ultrasound for cervical length always necessary at these follow-up visits?

Yes, assessing cervical length via transvaginal ultrasound is rated ‘Usually Appropriate’ by the ACR for multiple gestations. The increased uterine volume from twins and potential polyhydramnios significantly raises the risk of preterm labor. Routine cervical length screening is a key component of managing this risk.

Can I just order a ‘fetal growth ultrasound’ for these patients?

No, ordering a generic ‘growth ultrasound’ is a potential pitfall. You should specifically order a ‘Multiple gestation ultrasound for TTTS/TAPS/sFGR surveillance’ or similar, to ensure the sonographer and radiologist perform all the necessary components, including MVP fluid measurements for both sacs, bladder assessment, and umbilical artery and MCA Dopplers.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026